TrialEuropean journal of neurology2020

Positive response to galcanezumab following treatment failure to onabotulinumtoxinA in patients with migraine: post hoc analyses of three randomized double-blind studies.

J Ailani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.